Sertraline treatment of children and adolescents with obsessive- compulsive disorder or depression: Pharmacokinetics, tolerability, and efficacy

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 37, Issue 4, 1998, Pages 386-394

  Alderman, Jeffrey ^a   Wolkow, Robert ^a   Chung, Menger ^a   Johnston, Hugh F ^b  

^a PFIZER INC   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Adolescent; Child; Depression; Obsessive compulsive disorder; Pharmacokinetics; Pharmacotherapy; Sertraline

Indexed keywords

NORSERTRALINE; SERTRALINE;

ADOLESCENT; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; CHILD; CHILD PSYCHIATRY; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; HEADACHE; HUMAN; INSOMNIA; NAUSEA; OBSESSION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SOMNOLENCE;

EID: 0031967526     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-199804000-00016     Document Type: Article

References (38)

1. Alderman J, Preskorn SH, Greenblatt DJ et al. (1997), Desipramine pharmacokinetics when coadministered with paroxetine or sertraline in extensive metabolizers. J Clin Psychopharmacol 17:284-291
2. Bolden-Watson C, Richelson E (1993), Blockade of newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sci 52:1023-1029
3. Bomba J, Jaklewicz (1990), Depression in children at the beginning of school education: prevalence of the phenomenon and its relation to the child's adaptive capacity. Psychiatr Pol 24:15-19
4. Brumback RA, Weinberg WA (1990), Pediatric behavioral neurology: an update on the neurologic aspects of depression, hyperactivity, and learning disabilities. Neurol Clin 8:677-703
5. Chouinard G, Goodman W, Greist J et al. (1990), Results of a double-blind placebo controlled trial of a new serotonin uptake inhibitor, sertraline, in the treatment of obsessive compulsive disorder. Psychopharmacol Bull 26:279-284
6. Clarizio HF (1989), Continuity in childhood depression. Adolescence 24: 253-267
7. Cohn CK, Shrivestava R, Mendels J et al. (1990), Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients. J Clin Psychiatry 51 (suppl B):28-33
8. Doogan DP (1991), Toleration and safety of sertraline: experience worldwide. Int Clin Psychopharmacol 6(suppl 2):47-56
9. Doogan DP, Caillard V (1992), Sertraline in the prevention of depression. Br J Psychiatry 160:217-222
10. Douglass HM, Moffitt TE, Dar R, McGee R, Silva P (1995), Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry 34:1424-1431
11. Fabre LF, Abuzzahab FS, Amin M et al. (1995), Sertraline safety and efficacy in major depression: a double-blind, fixed-dose comparison with placebo. Biol Psychiatry 38:592-602
12. Garnier R, Azoyan P, Chataigner D, Taboulet P, Dellatre D, Efthymious M-L (1993), Acute fluvoxamine poisoning. J Int Med Res 21:197-208
13. Goodman WK, Price LH (1992), Assessment of severity and change in obsessive compulsive disorder. Psychiatr Clin North Am 15:861-869
14. Greenberg PE, Stiglin LE, Finkelstein SN, Berndt ER (1993), Depression: a neglected major illness. J Clin Psychiatry 54:419-424
15. Greist J, Chouinard G, DuBoff E et al. (1995a), Double-blind parallel comparison of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry 52:289-295
16. Greist JH, Jefferson JW, Kobak KA et al. (1995b), A 1-year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive compulsive disorder. Int Clin Psychopharmacol 10:57-65
17. Guy W (1976), Assessment Manual for Psychopharmacology, Revised (DHEW Publication ABM 76-338). Washington, DC: US Government Printing Office
18. Kurtz DL, Bergstrom RF, Goldberg MJ, Cerimale BJ (1994), Drug interaction between sertraline and desipramine and imipramine. J Clin Pharmacol 34:1009
19. March JS, Leonard HL, Swedo SE (1995), Neuropsychiatry of obsessive-compulsive disorder. Compr Psychiatry 21:507-512
20. Medical Economics Company (1997), Physicians' Desk Reference. Oradell, NJ: Medical Economics Company
21. Mendels J (1992), Clinical drug appraisal: sertraline. Drug Ther 22:37-48
22. Moreau DL (1990), Major depression in childhood and adolescence. Psychiatr Clin North Am 13:355-368
23. Muller E, Schapowahl A, Seelander A (1984), Catamnestic surveys on somatopsychosocial development in childhood and adolescence of patients with unipolar depressive and bipolar manic-depressive psychoses. Psychiatr Neurol Med Psychol (Leipz) 36:480-488
24. Murdoch D, McTavish D (1992), Sertraline: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder. Drugs 44:604-624
25. Murphy DL, Pickar D, Alterman IS (1982), Methods for the quantitative assessment of depressive and manic behavior. In: The Behavior of Psychiatric Patients, Burdick EI, Sudilovsky A, Gershon S, eds. New York: Marcel Dekker, pp 355-391
26. Pato MT, Zohar-Kadouch R, Zohar J, Murphy DL (1988), Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry 145:1521-1525
27. Preskorn SH (1993), Pharmacokinetics of psychiatric agents: why and how they are relevant to treatment. J Clin Psychiatry 54(suppl):3-12
28. Preskorn SH, Alderman J, Chung M, Harrison W, Messig M, Harris S (1994), Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine. J Clin Psychopharmacol 14:90-98
29. Reimherr FW, Chouinard G, Cohn CK et al. (1990), Amidepressant efficacy of sertraline: a double-blind, placebo- and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatry 51(suppl B):18-27
30. Riddle MA, Brown N, Dzubinski D, Jetmalani AN, Law Y, Woolston JL (1989), Fluoxetine overdose in an adolescent. J Am Acad Child Adolesc Psychiatry 28:587-588
31. Rodman JH (1994), Pharmacokinetic variability in the adolescent: implications of body size and organ function for dosage regimen design. J Adolesc Health 15:654-662
32. Ronfeld RA, Shaw GL, Tremaine LM (1988), Distribution and pharmacokinetics of the selective 5HT uptake blocker sertraline in man, rat, and dog. Psychopharmacology 96(suppl):269
33. Scahill L, Riddle M, McSwiggin-Hardin M et al. (1997), Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852
34. SIMED (1994), P-PHARM (software). Creteil, France: SIMED
35. Tadai T, Nakamura M, Okazaki S, Nakajima T (1995), The prevalence of obsessive-compulsive disorder in Japan: a study of students using the Maudsley Obsessional-Compulsive inventory and DSM-III-R. Psychiatry Clin Neurosci 49:39-41
36. Tremaine LM, Joerg EA (1989), Automated gas chromatographic-electron capture assay for the selective serotonin uptake blocker, sertraline. J Chromatogr 496:423-429
37. Wilson JT, Parish RC, del Mundo A, Jr., Johnson V (1995), Pharmacotherapy of depression in children. Curr Opin Pediatr 7:199-207
38. Zussman BD, Davis CC, Fowless SE et al. (1994), Sertraline like other SSRIs is a significant inhibitor of desipramine metabolism in vivo. Presentation to the British Pharmacological Society, December 16